EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity

Caio Foulkes, Nikolas Friedrich iD, Branislav Ivan, Emanuel Stiegeler, Carsten Magnus, Daniel Schmidt, Umut Karakus, Jacqueline Weber, Huldrych F Günthard, Chloé Pasin, Peter Rusert, Alexandra Trkola iD

PLOS Pathogens · 2025

DOI: 10.1371/journal.ppat.1012825 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Caio Foulkes und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Virology, University of Zurich (UZH), Zurich, Switzerland. Hauptthemen laut MEDLINE: HIV-1, HIV Antibodies, Antibodies, Neutralizing, env Gene Products, Human Immunodeficiency Virus. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, SHCS research foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For use in prevention and treatment, HIV-1 broadly neutralizing antibodies (bnAbs) have to overcome Env conformational heterogeneity of viral quasispecies and neutralize with constant high potency. Comparative analysis of neutralization data from the CATNAP database revealed a nuanced relationship between bnAb activity and Env conformational flexibility, with substantial epitope-specific variation of bnAb potency ranging from increased to decreased activity against open, neutralization-sensitive Env. To systematically investigate the impact of variability in Env conformation on bnAb potency we screened 126 JR-CSF point mutants for generalized neutralization sensitivity to weakly neutralizing antibodies (weak-nAbs) depending on trimer opening and plasma from people with chronic HIV-1 infection. 23 mutations resulted in a highly neutralization sensitive phenotype, which was associated with de-stabilization of the closed, prefusion conformation. Including 19 of these mutants into a Sensitivity Env mutant panel (SENSE-19), we classified bnAbs according to potency variations in response to trimer opening. To verify that these sensitivity patterns are independent of the in vitro assay system, replication-competent SENSE-19 mutant viruses were tested on primary CD4 T cells. While loss of potency on SENSE-19 was registered for bnAbs from several classes recognizing quaternary epitopes on pre-triggered Env, structural destabilization benefitted MPER bnAbs and other inhibitors known to have post-CD4 attachment neutralization activity. Importantly, for a subset of CD4bs bnAbs, and the interface bnAb PGT151, particularly low potency variation was noted, suggesting that Env conformational tolerance can be achieved but is not the rule. In summary, SENSE-19 screens revealed distinct tolerance levels to Env conformational intermediates between bnAbs that provide mechanistic insights in their function and broaden current neutralization breadth assessments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV AntibodiesAntibodies, Neutralizingenv Gene Products, Human Immunodeficiency VirusHIV InfectionsHumansProtein ConformationNeutralization TestsEpitopes

Substanzen

HIV AntibodiesAntibodies, Neutralizingenv Gene Products, Human Immunodeficiency VirusEpitopes

Autor:innen und Institutionen

  • Institute of Medical Virology, University of Zurich (UZH), Zurich, Switzerland.
  • Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.

ORCID-Profile: Nikolas Friedrich, Alexandra Trkola

Förderung

  • Swiss National Science Foundation
  • SHCS research foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Foulkes, C., Friedrich, N., Ivan, B., Stiegeler, E., Magnus, C., Schmidt, D., Karakus, U., Weber, J., Günthard, H. F., Pasin, C., Rusert, P., & Trkola, A. (2025). Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012825

Vancouver

Foulkes C, Friedrich N, Ivan B, Stiegeler E, Magnus C, Schmidt D, et al. Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1012825

BibTeX
@article{Foulkes2025,
  author = {Foulkes, Caio and Friedrich, Nikolas and Ivan, Branislav and Stiegeler, Emanuel and Magnus, Carsten and Schmidt, Daniel and Karakus, Umut and Weber, Jacqueline and Günthard, Huldrych F and Pasin, Chloé and Rusert, Peter and Trkola, Alexandra},
  title = {Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity},
  journal = {PLOS Pathogens},
  year = {2025},
  doi = {10.1371/journal.ppat.1012825}
}
Kostenlos starten →